Prostate Cancer Reports

Volume 7 Number 2
February 2019


Home > Prostate Cancer Reports > Volume 7, Year 2019 > Number 2, February



CONTENTS


CASE REPORTS
DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
INTEGRATIVE MEDICINE
PROGNOSIS
TREATMENT



CASE REPORTS

.

Kolli S, Asarian A, Genato R, Xiao P.
A Devastatingly "Minor" Relationship Between Male Breast Cancer and Prostate Cancer.
Cureus. 2018 Oct 17;10(10):e3463. doi: 10.7759/cureus.3463.
Source | FTL | Similar articles



.

Mitsui Y, Sadahira T, Maruyama Y, Wada K, Tanimoto R, Sugimoto M, Araki M, Watanabe M, Yanai H, Watanabe T, Nasu Y.
Burned-out Prostate Cancer? Primary Metastatic Cancer Not Detected on Repeat Biopsy.
Acta Med Okayama. 2018 Dec;72(6):605-609. doi: 10.18926/AMO/56380.
Source | FTL | Similar articles



.

Polverari G, Ceci F, Calderoni L, Cervati V, Farolfi A, Castellucci P, Fanti S.
Male Breast Cancer Detected by 68Ga-PSMA-11 PET/CT in a Patient With Prostate Cancer With Pelvic Lymph Node Metastasis.
Clin Genitourin Cancer. 2018 Dec 4. pii: S1558-7673(18)30779-1. doi: 10.1016/j.clgc.2018.11.020. [Epub ahead of print]
Source | FTL | Similar articles



.

Ricci M, Frantellizzi V, Bulzonetti N, De Vincentis G.
Reversibility of castration resistance status after Radium-223 dichloride treatment: Clinical evidence and Review of the literature.
Int J Radiat Biol. 2018 Dec 17:1-29. doi: 10.1080/09553002.2019.1558301. [Epub ahead of print]
Source | FTL | Similar articles



DIAGNOSIS

.

Dhondt B, De Bleser E, Claeys T, Buelens S, Lumen N, Vandesompele J, Beckers A, Fonteyne V, Van der Eecken K, De Bruycker A, Paul J, Gramme P, Ost P.
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
World J Urol. 2018 Dec 21. doi: 10.1007/s00345-018-2609-8. [Epub ahead of print]
Source | FTL | Similar articles



.

Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, Elashoff DA, Raman SS, Reiter RE.
PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.
J Urol. 2019 Jan;201(1):91-97. doi: 10.1016/j.juro.2018.08.043.
Source | FTL | Similar articles



.

Gupta M, Choudhury PS, Rawal S, Goel HC, Talwar V, Singh A, Sahoo SK.
Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop.
World J Nucl Med. 2018 Oct-Dec;17(4):261-269. doi: 10.4103/wjnm.WJNM_79_17.
Source | FTL | Similar articles



.

Johnson DC, Raman SS, Mirak SA, Kwan L, Bajgiran AM, Hsu W, Maehara CK, Ahuja P, Faiena I, Pooli A, Salmasi A, Sisk A, Felker ER, Lu DSK, Reiter RE.
Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging.
Eur Urol. 2018 Nov 30. pii: S0302-2838(18)30930-8. doi: 10.1016/j.eururo.2018.11.031. [Epub ahead of print]
Source | FTL | Similar articles



.

Kang Z, Min X, Weinreb J, Li Q, Feng Z, Wang L.
Abbreviated Biparametric Versus Standard Multiparametric MRI for Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
AJR Am J Roentgenol. 2019 Feb;212(2):357-365. doi: 10.2214/AJR.18.20103. Epub 2018 Dec 4.
Source | FTL | Similar articles



.

Luzzago S, Petralia G, Musi G, Catellani M, Alessi S, Di Trapani E, Mistretta FA, Serino A, Conti A, Pricolo P, Nazzani S, Mirone V, Matei DV, Montanari E, de Cobelli O.
Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?
Clin Genitourin Cancer. 2018 Oct 23. pii: S1558-7673(18)30554-8. doi: 10.1016/j.clgc.2018.10.006. [Epub ahead of print]
Source | FTL | Similar articles



.

Nandurkar R, van Leeuwen P, Stricker P, Woo H, Kooner R, Yuen C, O'Neill G, Ende D, Cusick T, Ho B, Hickey A, Emmett L.
68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery.
Br J Radiol. 2019 Jan 23:20180667. doi: 10.1259/bjr.20180667. [Epub ahead of print]
Source | FTL | Similar articles



.

Sarikaya I, Sarikaya A, Elgazzar AH, Caloglu VY, Sharma P, Baqer A, Caloglu M, Alfeeli M.
Prostate-specific antigen cutoff value for ordering sodium fluoride positron emission tomography/computed tomography bone scan in patients with prostate cancer.
World J Nucl Med. 2018 Oct-Dec;17(4):281-285. doi: 10.4103/wjnm.WJNM_87_17. Date of Web Publication: 26-Oct-2018
Source | FTL | Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION

.

Michael J, Howard LE, Markt SC, De Hoedt A, Bailey C, Mucci LA, Freedland SJ, Allott EH.
Early-Life Alcohol Intake and High-Grade Prostate Cancer: Results from an Equal-Access, Racially Diverse Biopsy Cohort.
Cancer Prev Res (Phila). 2018 Oct;11(10):621-628. doi: 10.1158/1940-6207.CAPR-18-0057. Epub 2018 Aug 23.
Source | FTL | Similar articles



.

Tsoi KKF, Ho JMW, Chan FCH, Sung JJY.
Long-term use of low-dose aspirin for cancer prevention: A 10-year population cohort study in Hong Kong.
Int J Cancer. 2018 Dec 21. doi: 10.1002/ijc.32083. [Epub ahead of print]
Source | FTL | Similar articles



INTEGRATIVE MEDICINE

.

Anderson-Carter I, Posielski N, Liou JI, Khemees TA, Downs TM, Abel EJ, Jarrard DF, Richards KA.
The impact of statins in combination with androgen deprivation therapyin patients with advanced prostate cancer: A large observational study.
Urol Oncol. 2019 Feb;37(2):130-137. doi: 10.1016/j.urolonc.2018.11.017. Epub 2018 Dec 7.
Source | FTL | Similar articles



PROGNOSIS

.

Bianchi L, Gandaglia G, Fossati N, Larcher A, Pultrone C, Turri F, Selli C, de Groote R, de Naeyer G, Borghesi M, Schiavina R, Brunocilla E, Briganti A, Montorsi F, Mottrie A.
Oncologic outcomes in prostate cancer patients treated with robot-assisted radical prostatectomy: results from a single institution series with more than 10 years follow up.
Minerva Urol Nefrol. 2018 Dec 14. doi: 10.23736/S0393-2249.18.03285-X. [Epub ahead of print]
Source | Abstract | Similar articles



.

Hervás A, Pastor J, González C, Jové J, Gómez A, Casaña M, Villafranca E, Mengual JL, Muñoz V, Henriquez I, Muñoz J, Collado E, Clemente J.
Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database.
Clin Transl Oncol. 2018 Dec 10. doi: 10.1007/s12094-018-02000-y. [Epub ahead of print]
Source | FTL | Similar articles



.

Gautier M, Aude M, Gerjon H, Jerome R, Jean S, Arnauld V, Mo S, Charles HR.
Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy.
BMC Cancer. 2018 Dec 27;18(1):1291. doi: 10.1186/s12885-018-5229-1.
Source | FTL | Similar articles



.

Gupta N, Bivalacqua TJ, Han M, Gorin MA, Challacombe BJ, Partin AW, Mamawala MK.
Evaluating the Impact of Length of Time from Diagnosis to Surgery in Patients with Unfavorable Intermediate to Very High-Risk Clinically Localized Prostate Cancer.
BJU Int. 2018 Dec 20. doi: 10.1111/bju.14659. [Epub ahead of print]
Source | FTL | Similar articles



.

Huang H, Muscatelli S, Naslund M, Badiyan SN, Kaiser A, Siddiqui MM.
Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger Than 60 Years.
J Urol. 2019 Jan;201(1):120-128. doi: 10.1016/j.juro.2018.07.049. Publication Date: 2019/01/01 .
Source | FTL | Similar articles



.

Keller EX, Bachofner J, Britschgi AJ, Saba K, Mortezavi A, Kaufmann B, Fankhauser CD, Wild P, Sulser T, Hermanns T, Eberli D, Poyet C.
Prognostic value of unifocal and multifocal positive surgical margins in a large series of robot-assisted radical prostatectomy for prostate cancer.
World J Urol. 2018 Dec 5. doi: 10.1007/s00345-018-2578-y. [Epub ahead of print]
Source | FTL | Similar articles



.

Murray NP, Aedo S, Fuentealba C, Reyes E, Jacob O.
Combining the Prostate Cancer Risk Index (PRIX) with the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure after Radical Prostatectomy for Prostate Cancer
Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3375-3381.
Source | FTL | Similar articles



.

Yang YJ, Kong YY, Li GX, Wang Y, Ye DW, Dai B.
Phenotypes of Circulating Tumor Cells Predict Time to Castration Resistance in Metastatic Castration-Sensitive Prostate Cancer.
BJU Int. 2018 Dec 7. doi: 10.1111/bju.14642. [Epub ahead of print]
Source | FTL | Similar articles



TREATMENT

.

Bass R, Fleshner N, Finelli A, Barkin J, Zhang L, Klotz L.
Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer.
J Urol. 2019 Jan;201(1):113-119. doi: 10.1016/j.juro.2018.07.040.
Source | FTL | Similar articles



.

Bill-Axelson A, Holmberg L, Garmo H, Taari K, Busch C, Nordling S, Häggman M, Andersson SO, Andrén O, Steineck G, Adami HO, Johansson JE.
Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up.
N Engl J Med. 2018 Dec 13;379(24):2319-2329. doi: 10.1056/NEJMoa1807801.
Source | FTL | Similar articles



.

De Bruycker A, De Bleser E, Decaestecker K, Fonteyne V, Lumen N, De Visschere P, De Man K, Delrue L, Lambert B, Ost P.
Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates.
Eur Urol. 2018 Nov 28. pii: S0302-2838(18)30839-X. doi: 10.1016/j.eururo.2018.10.044. [Epub ahead of print]
Source | FTL | Similar articles



.

King MT, Nguyen PL, Boldbaatar N, Tempany CM, Cormack RA, Beard CJ, Hurwitz MD, Suh WW, D'Amico AV, Orio PF 3rd.
Long-term outcomes of partial prostate treatment with magnetic resonance imaging-guided brachytherapy for patients with favorable-risk prostate cancer.
Cancer. 2018 Sep 1;124(17):3528-3535. doi: 10.1002/cncr.31568. Epub 2018 Jul 5.
Source | FTL | Similar articles



.

Lohaus F, Zöphel K, Löck S, Wirth M, Kotzerke J, Krause M, Baumann M, Troost EGC, Hölscher T.
Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease?
Eur Urol. 2018 Dec 18. pii: S0302-2838(18)30954-0. doi: 10.1016/j.eururo.2018.11.050. [Epub ahead of print]
Source | FTL | Similar articles



.

Nieder C, Haukland E, Mannsåker B, Pawinski A, Yobuta R, Norum J.
Initiation of Systemic Therapy During the Last 30 Days of Life in Patients With Metastatic Castration-resistant Prostate Cancer.
Anticancer Res. 2019 Jan;39(1):335-340. doi: 10.21873/anticanres.13116.
Source | FTL | Similar articles



.

Rotinen M, You S, Yang J, Coetzee SG, Reis-Sobreiro M, Huang WC, Huang F, Pan X, Yáñez A, Hazelett DJ, Chu CY, Steadman K, Morrissey CM, Nelson PS, Corey E, Chung LWK, Freedland SJ, Di Vizio D, Garraway IP, Murali R, Knudsen BS, Freeman MR.
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis.
Nat Med. 2018 Dec;24(12):1887-1898. doi: 10.1038/s41591-018-0241-1. Epub 2018 Nov 26.
Source | FTL | Similar articles



.

Roviello G, Gallicchio R, Bozza G, Rodriquenz MG, Aieta M, Storto G.
Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223.
Onco Targets Ther. 2018 Dec 17;12:9-13. doi: 10.2147/OTT.S174206. eCollection 2019.
Source | FTL | Similar articles



.

Shulman RM, Meyer JE, Li T, Howell KJ.
External beam radiation therapy (EBRT) for asymptomatic bone metastases in patients with solid tumors reduces the risk of skeletal-related events (SREs).
Ann Palliat Med. 2018 Nov 6. pii: apm.2018.10.04. doi: 10.21037/apm.2018.10.04. [Epub ahead of print]
Source | FTL | Similar articles



.

Tran LNK, Kichenadasse G, Morel KL, Lavranos TC, Klebe S, Lower KM, Ormsby RJ, Elliot DJ, Sykes PJ.
The Combination of Metformin and Valproic Acid Has a Greater Anti-tumoral Effect on Prostate Cancer Growth In Vivo than Either Drug Alone.
In Vivo. 2019 Jan-Feb;33(1):99-108. doi: 10.21873/invivo.11445.
Source | FTL | Similar articles



.

Tsumura H, Ishiyama H, Tabata KI, Sekiguchi A, Kawakami S, Satoh T, Kitano M, Iwamura M.
Long-term outcomes of combining prostate brachytherapy and metastasis-directed radiotherapy in newly diagnosed oligometastatic prostate cancer: A retrospective cohort study.
Prostate. 2018 Dec 26. doi: 10.1002/pros.23757. [Epub ahead of print]
Source | FTL | Similar articles



bottom